The Treatment of Chloroquine-Resistant Malaria

Tropical Doctor

Volumn 29, Issue 3, 1999, Pages 176-179

  Van Vugt, Michele ^a,c   White, Nicholas J ^a,b,d  

^a SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ATOVAQUONE PLUS PROGUANIL; BENFLUMETOL; CHLOROQUINE; FANSIDAR; HALOFANTRINE; MEFLOQUINE; PYRONARIDINE; QUININE;

HUMAN; MALARIA; SHORT SURVEY;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

CINCHONA PUBESCENS;

EID: 0032779964     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1177/004947559902900321     Document Type: Article

References (23)

1. White NJ. Antimalarial drug resistance: the pace quickens. J Antimcrob Chemother, 1992; 30: 571-85
2. Nevill CG, Verhoeff FH, Munafu CG, ten Hove WR, van der Kaay HJ, Were JB. A comparison of amodiaquine and chloroquine in the treatment therapy of falciparum malaria in Kenya. E Afr Med J, 1994; 71: 167-70
3. Olliaro P, Nevill C, Lebras J et al., Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet, 1996; 348: 1196-201
4. Muller O, van Hensbroek MB, Jaffar S et al., A randomized trial of chloroquine, amodiaquine and pyrimethamine—sulphadoxine in Gambian children with uncomplicated malaria. Trop Med Int Health, 1996; 1: 124-32
5. Smithuis FM, Monti F, Grundi M, Oo A Zaw, Kyaw TT, Phe O, White NJ. In vivo sensitivity of Plasmodium falciparum to chloroquine, sulphadoxine—pyrimethamine, and mefloquine in Rakhine Staet, Western Myanmar. Trans R Soc Trop Med Hyg, 1997; 91: 468-72
6. Watkins WM, Mosobo M. Treatment of Plasmodium falciparum malaria with pyrimethamine—sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Trans R Soc Trop Med Hyg, 1993; 87: 75-8
7. Watkins WM, Brandling-Bennett AD, Nevill CG et al., Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum infection in Kenya. Trans R Soc Trop Med Hyg, 1988; 82: 398-403
8. Edstein MD, Shanks GD, Isavadharm P Teja, Rieckmann KH, Webster HK. Oxidative activation of proguanil and dapsone acetylation in Thai soldiers. Br J Clin Pharmacol, 1994; 37: 67-70
9. Luxemburger C, Price RN, Nosten F, ter Kuile F, Chongsuphajaisiddhi T, White NJ. Mefloquine in infants and young children. Ann Trop Paediatr, 1996; 16: 281-6
10. ter Kuile FO, Nosten F, Luxemburger C et al., Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious effects in 3673 patients. Bull WHO, 1995; 73: 631-42
11. Nosten F, Luxemburger C, ter Kuile FO et al., Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate—mefloquine combination. J Infect Dis, 1994; 170: 971-7
12. Kremsner PG, Winkler S, Brandts C, Neifer S, Bienzle U, Graninger W. Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. J Infect Dis, 1994; 169: 467-70
13. Looareesuwan S, Wilairatana P, Vanijanonta S, Kyle D, Webster K. Efficacy of quinine—tetracycline for acute uncomplicated falciparum malaria in Thailand. [Letter]. Lancet, 1992; 339: 369
14. ter Kuile FO, Dolan G, Nosten F et al., Halofantrine versus mefloquine in the treatment of multi-drug resistant falciparum malaria. Lancet, 1993; 341: 1044-9
15. Nosten F, ter Kuile FO, Luxemburger C et al., Cardiac effects of antimalarial treatment with halofantrine. Lancet, 1993; 341: 1054-6
16. Hien TT, White NJ. Qinghaosu. Lancet, 1993; 341: 603-8
17. White NJ. Preventing antimalarial drug resistance through combinations. Drug Resistance Updates, 1998; 1: 3-9
18. van Hensbroek MB, Onyiorah E, Jaffar S et al., A controlled trial of artemether or quinine in children with cerebral malaria. N Engl J Med, 1996; 335: 69-75
19. Hien TT, Day NPJ, Phu NH et al., A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med, 1996; 335: 76-83
20. Hien TT, Arnold K, Vinh H et al., Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg, 1992; 86: 582-3
21. van Vugt M, Brockman A, Gemperli B et al., A randomised comparison of artemether—benflumetol and artesunate—mefloquine in the treatment of multi-drug resistant falciparum malaria. Antimicrobial Agents Chemother, 1998; 42: 135-9
22. Looareesuwan S, Kyle DE, Viravan C, Vanijanonta S, Wilairatana P, Wernsdorfer WH. Clinical study of pyronaridine for the treatment of acute uncomplicated flaciparum malaria in Thailand. Am J Trop Med Hyg, 1996; 54: 205-9
23. Looareesuwan S, Viravan C, Webster HK, Kyle DE, Hutchinson DB, Canfield CJ. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg, 1996; 54: 62-6